Callan JMB

Callan JMB FCF Growth

The Year-over-Year Free Cash Flow Growth of Callan JMB (CJMB) as of Oct 23, 2026 is -1,144.87 %. In the previous year, Year-over-Year Free Cash Flow Growth was -92.40 % — a change of 1,138.99% (lower).

FCF Growth

-1,144.87 %

YoY

1,138.99%

Last updated:

Year-over-Year Free Cash Flow Growth of Callan JMB is 2025 -1,144.87 % . Year-over-Year Free Cash Flow Growth of Callan JMB was 2024 -92.40 % . It decreases by 1,138.99% lower compared to the previous year.

The Callan JMB FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2023
-27.24 USD
Jan 1, 2024
-92.40 USD
Jan 1, 2025
-1,144.87 USD
The Callan JMB FCF Growth history
YEARFCF GrowthYoY
-1,144.87 %+1,138.99%
-92.40 %+239.23%
-27.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Callan JMB Stock analysis

What does Callan JMB do? Callan JMB Inc provides thermal management logistics solutions for the life sciences industry, including personalized medicine, cell therapies, and vaccines. The company's Ship2Q ultraviolet disinfection process ensures thermal reliability and cleanliness of packaging systems. Its vertically integrated model combines proprietary packaging, IT, and cold chain logistics expertise to serve clients requiring cryogenic or frozen shipping. The firm targets life sciences companies needing specialized shipping solutions for temperature-sensitive products. Callan JMB Inc's primary products include thermal management logistics services and the Ship2Q disinfection process. These solutions address the full range of frozen shipping needs in the life sciences sector. The company serves manufacturers of biopharmaceuticals, diagnostic materials, and other temperature-sensitive commodities. Its services ensure that shipping systems meet manufacturer specifications for fitness and thermal performance. The company's business model focuses on providing comprehensive alternatives to traditional logistics solutions for frozen shipping. It operates as a vertically integrated provider, handling all aspects of cold chain logistics from packaging to delivery. Callan JMB Inc's target clients are life sciences companies requiring reliable, temperature-controlled shipping for sensitive materials like cell lines, cord blood, and organs. The firm's proprietary technology differentiates it in the specialized logistics market. Callan JMB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Callan JMB stock

Year-over-Year Free Cash Flow Growth of Callan JMB is -1,144.87 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Callan JMB since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Callan JMB historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Callan JMB

All Key Metrics — Callan JMB